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Abstract
Background: Cancer-Associated Fibroblasts (CAFs) are significant components of solid malignancies and play
central roles in cancer sustainability, invasion and metastasis. In this study we have investigated the invasive
capacity and matrix remodelling properties of human lung CAFs after exposure to ablative doses of ionizing
radiation (AIR), equivalent to single fractions delivered by stereotactic ablative radiotherapy (SART) for medically
inoperable stage-I/II non-small-cell lung cancers.
Methods: CAFs were isolated from lung tumour specimens from 16 donors. Initially, intrinsic radiosensitivity was
evaluated by checking viability and extent of DNA-damage response (DDR) at different radiation doses. The
migrative and invasive capacities of CAFs were thereafter determined after a sub-lethal single radiation dose of 18
Gy. To ascertain the mechanisms behind the altered invasive capacity of cells, expression of matrix
metalloproteinases (MMPs) and their endogenous inhibitors (TIMPs) were measured in the conditioned media
several days post-irradiation, along with expression of cell surface integrins and dynamics of focal contacts by
vinculin-staining.
Results: Exposing CAFs to 1 × 18 Gy resulted in a potent induction of multiple nuclear DDR foci (> 9/cell) with
little resolution after 120 h, induced premature cellular senescence and inhibition of the proliferative, migrative and
invasive capacity. AIR promoted MMP-3 and inhibited MMP-1 appearance to some extent, but did not affect
expression of other major MMPs. Furthermore, surface expression of integrins a2, b1 and a5 was consistently
enhanced, and a dramatic augmentation and redistribution of focal contacts was observed.
Conclusions: Our data indicate that ablative doses of radiation exert advantageous inhibitory effects on the
proliferative, migratory and invasive capacity of lung CAFs. The reduced motility of irradiated CAFs might be a
consequence of stabilized focal contacts via integrins.
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Background
Stereotactic ablative radiotherapy (SART), or stereotactic
body radiotherapy (SBRT), represents a novel technique
with particular impact on medically inoperable stage I
non-small-cell lung cancers (NSCLC) [1,2]. The
enhanced accuracy offered by SART allows for delivery
of high (or ablative) doses of ionizing radiation (IR) in
oligofractionated regimens, resulting in remarkable
tumour control with minimal toxicity [3]. Despite these
encouraging clinical results, our knowledge of the radio-
biological mechanisms associated with ablative radio-
therapy (RT) is still limited.
There is increasing awareness that solid malignancies
do not only contain transformed neoplastic cells, but are
rather composed of a mixed population of cells and
extracellular matrix that collectively constitute the
tumour microenvironment, also known as the tumour
stroma [4]. Reactive fibroblasts are frequently found in
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the stroma of human carcinomas, and their presence in
large numbers is associated with high-grade malignancy
and poor prognosis. Among multiple functions that con-
tribute to tumorigenesis, CAFs are active providers of
collagens, fibronectins, laminin, tenascin and proteogly-
cans, as well as ECM-degrading enzymes such as
MMPs, cathepsins and plasminogen activator [5,6]. Stro-
mal fibroblasts have also been shown to play a key role
in the process of invasion by “paving the path” for
tumour cells [7] or serving as initiators and stabilisers of
tumour vessels [8]. Hence, by migrating and degrading
matrix, CAFs make a direct contribution to tumour cell
invasion, tumour vessel formation, and tumour growth
[9].
It is evident that therapeutic irradiation of tumours
will inevitably affect the total tumour stroma. Despite
this undeniable fact; only limited knowledge is available
regarding the responses of reactive fibroblasts to radia-
tion. The importance of CAFs in the context of radia-
tion has been revealed by others, thus recent reports
indicate that fibroblasts of the pancreas may exert radio-
protective effects over the malignant counterparts [10].
Overall, very few studies have been conducted with
freshly isolated fibroblast from human tumour speci-
mens [11,12]. Previous reports using cell lines have
shown that after relatively high radiation doses, fibro-
blasts develop a senescent phenotype over several days
with a concomitant and permanent DNA damage
response, and acquire a pro-tumorigenic phenotype that
favours tumour development through the release of
paracrine signals [13-15]. In the context of SART, large
individual radiation doses may have “ablative” effects on
malignant cells but tumour stromal fibroblasts, which
are relatively radioresistant, may survive the radiation
insult. Hence, the ultimate effects of such large indivi-
dual doses may be even more dependent on stromal
components than conventional fractionated radiotherapy
[16-18]. The aim of this study was to investigate the
impact of ablative doses of ionizing radiation on CAFs
freshly isolated from human lung cancers (NSCLCs),
focusing on their migratory and matrix remodelling
properties.
Methods
Human material, cell isolation and CAF cultures
Human CAFs were harvested from freshly resected non-
small cell lung carcinoma (NSCLC) tumour tissues.
Tumours from 16 patients were included in this study
(Table 1). The Regional Ethical Committee approved the
study, and all patients provided written informed con-
sent. Fibroblasts from tumours were isolated using the
out-growth method and characterized by specific antibo-
dies. Briefly, tumour resections were collected and cut
into 1-1.5 mm3 pieces. Enzymatic digestion of tissues
was carried out for 1.5 h with collagenase (Cat. no. C-
9407 Sigma-Aldrich, St. Louise, MO, USA), at a final
concentration of 0.8 mg/mL. Pure fibroblast cultures
were obtained by selective cell detachment from the pri-
mary culture mix, and by further cell propagation in the
presence of 10% FBS. Cells were grown at 3% oxygen
levels and used for experiments after the second passage
(2-3 weeks). Antibodies: FITC-conjugated anti-human
a-SMA (smooth muscle a-actin) antibody (Abcam; Cat.
# ab8211), FITC-conjugated anti-IgG antibody (negative
control) and anti-human FAP (Fibroblast Activation
Protein) a-antibody (Abcam; Cat. # ab53066).
Irradiation of cells
Radiation protocols were established after initial dose-
escalating pilot trials, and by comparing single dose with
fractionated schedules. Hence, adherent CAFs were irra-
diated with high energy photons produced by a Varian
clinical linear-accelerator, delivered as single doses of 2,
6, 12 and 18 Gy or as 6 × 3 Gy in 24-h intervals. Stan-
dard parameters for dose delivery was depth 30 mm,
beam quality 15 MV, dose-rate 6 Gy/min and field size
20 × 20 cm. Radiation-doses were confirmed to be cor-
rect within an acceptable ± 4% by Thermo-Luminescent
Dosimeters (TLDs). Cell survival/death after radiation
was assessed by checking the extent of cell detachment
by light microscopy during the following three weeks.
Standard assays to test viability, such as MTT and “Clo-
nogenic assay” could not be used in our system since
Table 1 Donor features corresponding to the CAF cell
lines used in this study
Donors Age (years) Sex Tumourtype T-size (mm) T-stage
1 71 M BAA 20 1a
2 72 F BAA 16 1a
3 70 M AC 23 1b
4 72 F SCC 32 2b
5 63 M AC 30 1b
6 78 M AC 38 2b
7 78 M SCC 20 1a
8 48 F AC 13 1a
9 69 F AC 30 1b
10 73 M SCC 18 1a
11 64 F AC 8 1a
12 50 M LCC 50 2a
13 64 M AC 7 1a
14 51 M AC 60 2a
15 72 F SCC 40 2a
16 73 M AC 11 1a
Abbreviations: BAA = bronchio alveolar adenocarcinoma; AC = adenocarcinoma
SCC = Squamous cell carcinoma; LCC = Large cell carcinoma; M = male; F =
female
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the differences observed after long incubation periods
between irradiated and non-irradiated cells were a con-
sequence of premature cell senescence rather than cell
death. Of note, in our internal control experiments all
cells were able to exclude trypan blue, and no cell
detachment was observed over three weeks in culture
post-irradiation.
Immunofluorescence staining
CAFs were cultured in 2-well chamber slides (Nunc,
Thermo Fisher Scientific, NY, USA), fixed with 4% PFA-
PBS for 10 min and permeabilized with 0.2% Triton-
PBS for 8 min. Slides were then exposed to blocking
buffer (2% HSA-PBS). Next; primary antibodies (Rabbit
anti human 53BP1; Cat.#ab36823, or monoclonal anti-
human Vinculin, Cat.#ab11194, Abcam Cambridge, UK)
were diluted in blocking buffer and incubated with
CAFs for 45 min at RT. After washing, cells were incu-
bated with secondary antibody (anti-rabbit-Alexa546,
Cat. #A11010, or anti-mouse-Alexa488, Cat. #A11110
Molecular Probes/Invitrogen, Leiden, The Netherlands)
in blocking buffer, 30 min at RT. A second wash was
followed by preparation of slides in DAPI-Fluoromount-
G (Cat. # 0100-20, Southern Biotech, Birmingham, AL,
USA). Specimens were examined in a fluorescence
microscope (Zeiss Axiophot, Germany) equipped with a
Nikon DS-5MC digital camera, and images were pro-
cessed with Adobe® Photoshop Software (CS5).
Real-time monitoring of density dependent growth
To monitor cellular adhesion and growth responses we
have exploited the “xCELLigence” system from Roche
Applied Sciences (Indianapolis, IN), consisting of micro-
titer plates (E-plates) with integrated gold microarrays
in the bottom of wells for continuous and label-free
measurements of cellular status in real-time by the
RTCA-DP instrument. Cell status is measured by elec-
trical impedance and the relative change between impe-
dance measured at any time (t) and baseline at time
zero (t0) is displayed as the dimensionless parameter
“Cell Index” (CI). In standard E-plates, CI-values are
proportional to number of cells attached, and the kinetic
profiles generated thus reflect adhesion and spreading
within the first ~6 h upon seeding and thereafter mirror
cell growth (increasing CI) and/or cell death (decreasing
CI) [19-21]. In our study, control and irradiated CAFs
from four randomly selected donors were brought into
suspension and seeded in E-plates at a density of 6000
cells/well. E-plates were then transferred to the RTCA-
DP instrument for automated real-time monitoring at
standard incubator conditions, with quadruplet read-
outs of the parameter “Cell Index” every 30 min the fol-
lowing 7 days.
Real-time monitoring of cellular migration and invasion
Onset and rate of migration and invasion was also mon-
itored by the “xCELLigence-system” as explained above,
but using CIM (Cell Invasion-and-Migration)-plates
rather than E-plates. CIM-plates feature microelectronic
sensors located on the underside of a microporous
membrane insert [22]. Cells capable of migrating from
the upper chamber through the membrane and into the
bottom chamber will contact and adhere to the sensors,
resulting in increased impedance and hence increased
“Cell Index” read-outs. Our migration assays were per-
formed by seeding control and irradiated CAFs in the
upper chamber of CIM-plates in serum-free medium
and at a density of 50,000 cells per well. Bottom cham-
bers of the CIM-plates were filled with serum-contain-
ing medium to promote migration across membranes
towards the serum gradient. After seeding, CIM-plates
were transferred into the RTCA DP instrument for con-
tinuous read-outs during 48 h. Impedance (i.e. “Cell
index”) was registered only from cells capable of migrat-
ing through the 8 μm porous membranes, and was per-
formed in triplicates. For invasion assays, protocols
identical to that for migration were followed, with the
exception that upper chambers were loaded with 30 μL
of a 1:10 dilution of Matrigel to create a 3D biomatrix
film in each well prior to cell loading. For comparison,
each pull of non-irradiated CAFs was also seeded in
duplicates on Matrigel-free wells, reflecting pure migra-
tory behaviour.
b-galactosidase assays
CAFs were seeded at a density of 20,000 cells per well in
6-well plates and left for attachment and spreading for
24 h prior to irradiation. Five days post-irradiation cul-
tures were washed and fixed for 5-7 min at RT with
PFA (2%). b-galactosidase (5-bromo-4chloro-3-indolyl-
B-D-galactopyranoside) staining was achieved following
instructions from the manufacturer; “Senescence Cells
Histochemical Staining Kit” (Cat.no CS0030, Sigma-
Aldrich, St. Louise, MO, USA). Number of b-galactosi-
dase active and senescent cells was determined by
counting blue cells on 3 randomly selected fields under
a Nikon Eclipse TS100 model light microscope. Ran-
domly selected fields were photographed at 1000× mag-
nification, using an Idea SPOT digital camera.
Fluorescent bead-based fluorokine-multi analytes
profiling assay (Luminex)
Quantitative measurements of MMPs and TIMPs were
performed using a suspension array technique (Bio-plex
200, Bio-Rad, CA, USA). Five days post-irradiation CAF
culture medium from five randomly selected donors was
conditioned for 24 h. Protein levels of MMPs (MMP-1,
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-2, -3, -7, -8, -9, and -13) were analysed with a MMP
multiplex kit (Cat. No. LMP-000, R&D Systems, MI,
USA), whereas levels of TIMPs (TIMP-1, -2, -3 and -4)
were analysed with a TIMP multiplex kit (Cat. No.
LKT-003, R&D Systems). Samples were run in dupli-
cates, and in dilutions 1:5 (MMPs) or 1:10 (TIMPs).
Levels of MMPs and TIMPs were detected using the
Bio-plex 200 analyser, according to instructions from
the manufacturer. Data were analysed using SPSS statis-
tical software version 16.0 (SPSS Inc., Chicago, IL,
USA). Secretion of MMPs and TIMPS were examined
for statistical significance using the Wilcoxon signed-
rank test. All data are expressed as mean ± standard
error of the mean (SEM). A p-value < 0.05 denoted the
presence of a statistically significant difference.
Flow cytometry
Adherent cultures of CAFs were grown in 6-well plates
to 50% confluence and then irradiated, followed by incu-
bation for another 5 days. Irradiated and control cells
were detached by exposure to EDTA-PBS (2 mM), and
fixed in cold 2%PFA-PBS. After fixation cells were kept
in blocking solution (HSA-PBS) followed by exposure to
FITC-conjugated anti-integrin antibodies (a2, a5 and
b1, Cat.# ab30486, ab78043, ab46920 respectively,
Abcam, Cambridge, UK) for 1 h at 22°C. Unlabeled anti-
bodies were eliminated by a series of cell washings.
CAFs incubated with FITC-conjugated IgG antibodies
represented negative controls. Surface binding of pri-
mary antibodies was quantified on a Becton Dickinson
FACScan flow cytometer. Cellular profiles were gated
on intact cells, and were based on morphology and
mean fluorescent intensity.
Western blots
Six days post-irradiation attached cells were lysed in 500
μl RIPA lysis buffer (cat. no. 20-188, Millipore) contain-
ing protease inhibitors (cat. no. 20-201, Millipore). Pro-
tein content was measured by the Bradford assay (Bio-
Rad Laboratories, CA, USA). Equal amounts of protein
per sample were run in NuPAGE, Novex and Tris-
Acetat Mini Gels (Invitrogen, Carlsbad, CA, USA) 4-
12% by reduced conditions, and proteins were trans-
ferred to a PVDF (Pierce, Rockford, IL, USA) membrane
and incubated with primary antibodies at 4°C overnight.
Protein binding was visualized by the application of a
secondary antibody, i.e. HRP-conjugated goat anti-rabbit
IgG antibody (Cat.#: AP307P; Millipore).
Results
Isolation, characterization and purity of CAFs
All the data generated in this study comes from cells
directly prepared from lung tumour specimens
obtained from different donors after surgical resection
(Table 1). Tumour stromal fibroblasts were isolated by
the outgrowth method, purified by selective cell
detachment and expanded in serum-containing med-
ium. Cells were ready for experimentation three weeks
after tissue collection. Cell authentication and purity
was checked by flow cytometry of cells exposed to the
fibroblast specific marker smooth muscle a-actin (a-
SMA) (Figure 1A). Analyses showed a single cell popu-
lation 100% positive for a-SMA. Additionally, the reac-
tive nature of the fibroblasts was checked by specific
immuno staining with anti-fibroblast activation protein
(FAP) antibody [23,24] (Figure 1B). All adherent cells
in the cultures had a strong immuno-reactivity for
FAP.
Cellular responses to dose-escalating radiation exposures
Initial experiments were conducted to test the intrinsic
radiosensitivity of CAFs by examining viability and DNA
damage responses after different radiation doses. CAF
cultures from two different donors were exposed to sin-
gle radiation doses of 2, 6, 12 or 18 Gy and a fractio-
nated regimen of 6 × 3 Gy. Induction and repair of
DNA damage was determined by quantifying 53BP-1
containing nuclear foci, 24 h and 5 days post-irradiation
(Figure 1C-F). Of note, no cell death was observed after
any of the radiation regimens over a 3 weeks period,
assessed by light microscopy (data not shown). Addi-
tionally, no reduction in cell viability was registered by
“xCELLigence” during the first week post-irradiation (18
Gy) (Figure 2A). After low doses of radiation (2 Gy),
resolution of 53BP-1 foci was observed over 24 h as
expected (Figure 1D). After higher doses, foci persisted
for longer periods of time, consistent with the senescent
phenotype [25,26]. Persistence of foci at 120 h was
much less marked after 6 × 3 Gy than after a single
dose of 18 Gy (Figure 1E-F).
Reduced proliferative capacity and induction of cell
senescence
Considering that a single dose of 18 Gy was able to
induce a sustained DDR in CAF cultures, and that such
dose is clinically relevant in the context of SART, its
effect on proliferative capacity was assessed. Prolifera-
tion rates of CAFs from all donors were reduced after
18 Gy (Figure 2A). In parallel experiments, induction of
cell senescence by b-galactosidase staining was mea-
sured six days after 18 Gy (single fraction) or 24 h after
6 daily fractions of 3 Gy (Figure 2B). Irradiated cultures
showed prominent induction of b-galactosidase staining,
suggesting that a large number of irradiated CAFs
entered growth arrest by activating premature cell
senescence mechanisms. The senescence response was
more pronounced after 1 × 18 Gy than after 6 × 3 Gy
(p < 0.05) (Figure 2C).
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Effects of AIR on migratory and invasive capacity
We went on to investigate the functional status of irra-
diated cells, with particular emphasis on invasion and
migration, which have previously been shown to
influence tumour invasiveness and angiogenesis. Irradia-
tion of CAFs from all donors was associated with a sig-
nificant drop in their migratory capacity (Figure 3). The
migratory activity of irradiated cells was on average 67%
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Figure 1 Characterization of cultures and dynamics of 53BP-1 nuclear foci formation in dose-escalating IR exposures: In (A), flow
cytometry of CAFs after staining cells with a-SMA antibody. Panel (B) shows immunostaining of CAFs with a-FAP. Fluorescence micrographs in
(C) show staining with anti-53BP-1 (red/pink) and DAPI (blue). Induction of DNA damage response (DDR) and extent of repair was determined
by counting percentage of cells showing nuclear foci staining of 53BP-1 at early (24 h; D) and late (5 days; E) time points. Columns in (D) and
(E) each represent average counts from two randomly selected donors (n = 2) (donors #15 and #16). In panel (F), percentage cells with multi-
foci (> 9/cell) in (D) and (E) are plotted versus time.
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(± 4.8) lower than non-irradiated cells when calculated
48 h after exposure to 1 × 18 Gy. The invasive capacity
of irradiated CAFs across a biofilm of Matrigel was con-
sistently abridged in all donors, averaging 66% (± 15.9%)
reduction when compared with controls. However, the
statistical analyses revealed not significant differences in
values taken at the end point of the experiment (p =
0.09) (Figure 4). Overall, these results indicate that while
CAFs appear to survive high radiation doses, their
migratory and invasive capacity is considerably
compromised.
Figure 2 Attenuation of the proliferative capacity of irradiated CAFs, and induction of premature senescence: (A) Proliferation curves
monitored over one week of non-irradiated cells (grey line) and cells receiving 1 × 18 Gy (black line) from four randomly selected donors
(donors #15, #6, #7, #8 in Table 1). In lower panel, statistically significant differences found after applying paired sample t-test on values at the
end point of the experiments are marked with * (p < 0.05). (B) b-galactosidase staining assay in CAFs from one randomly selected donor. The
percentage of b-galactosidase positive cells in each condition was calculated from three different donors (donors #1, #7, #11 respectively from
Table 1) and plotted in (C). Statistically significant differences are marked with * (p < 0.05).
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Effects of AIR on expression of ECM regulators
After verifying that AIR reduces the invasive capacity of
CAFs, we investigated potential mechanisms. Quantita-
tive measurements of MMPs and their endogenous inhi-
bitors, TIMPs, in culture supernatants were performed
by multiplex protein detection assays (Figure 5A, B) in
conditioned medium of CAFs from five donors. MMP-2
was the most abundantly expressed MMP, followed by
MMP-1 and MMP-3 (Figure 5A). Expression levels of
the latter two enzymes varied widely between CAFs
from different donors. Conversely, MMP-7, MMP-8,
MMP-9 and MMP-13 expression were below the detec-
tion limit of the assay (< 25 pg/ml) for both irradiated
and non-irradiated CAFs (not shown). Comparative
analyses showed that for 4 out of 5 donors, radiation of
CAFs resulted in reduced secretion of MMP-1 (48% ±
23). No such reduction in MMP-1 secretion was
observed in CAFs from a 5th donor (donor #7), but it is
noteworthy that irradiation of CAFs from this donor
caused a significant reduction in their migrative and
invasive capacity (top right panel of Figures 3 and 4,
respectively). This indicates that regulation of MMP-1
expression may play a minor or inconsistent role in reg-
ulating the invasive properties of CAFs. On the other
hand, expression pattern for MMP-3 was modestly but
consistently elevated following radiation in all five cell
pairs (29% ± 17, p < 0.05). Regarding protease inhibitors,
only TIMP-1, -2, and -3 could be detected in
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assay was run for 48 h. Columns in the lower panel represent average CI values at the end of the experiment from the four donors. Statistically
significant differences found after applying paired sample t-test on values at the end point of the experiments are marked with * (p < 0.05).
Hellevik et al. Radiation Oncology 2012, 7:59
http://www.ro-journal.com/content/7/1/59
Page 7 of 13
supernatants and no consistent alterations in their
expression after AIR could be detected (Figure 5B). To
assess the potential role played by the different MMPs
on the invasive function of CAFs, the activity of CAFs-
derived MMPs was abrogated by the exogenous admin-
istration of GM1489 (Calbiochem, Cat.# 364200, Merck
KGaA, Darmstadt, Germany), a broad spectrum inhibi-
tor of matrix metalloproteinases with high affinity for
MMP-1 (Ki = 0.2 nM), and lower affinity for other
MMPs (Ki = 500 nM for MMP2; Ki = 20 μM for MMP-
3; Ki = 100 nM for MMP-8 and MMP-9). The invasion
assays were carried out at increasing concentration of
the inhibitor as indicated in Additional file 1: Figure
S1A. At the lowest concentration of inhibitor (1 nM)
more than 90% of MMP-1 activity should be blocked,
however this amount if inhibitor exerted only 18% inhi-
bition of invasion, whereas the invasion rates were
reduced to approximately 50% at the highest concentra-
tion tested (10 μM) (Additional file 1: Figure S1B).
Induction of cell surface integrin expression, cell
adhesiveness and regulation of focal contacts
Last, we examined whether reduced motility of CAFs
was linked to changes in expression of cell surface integ-
rins and/or stabilization of focal contacts. Non-irradiated
CAFs showed accumulation of vinculin in focal contacts
distributed primarily at the periphery of cells (Figure
6A). Upon 1 × 18 Gy exposure the cellular distribution
of focal contacts changed significantly: after 5 days
CAFs showed a more flattened morphology and numer-
ous focal contacts were distributed around the perimeter
of cells. Furthermore, the surface expression of some
ECM receptors was evaluated. Collagens and non-col-
lagenous proteins such as laminin and fibronectin are
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Figure 4 Effects of AIR on the invasion capacity of CAFs. Invasion curves of CAFs prepared from four randomly selected donors (donors #11,
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abundantly expressed extracellular matrix components
in the interstitial stroma of solid tumours. These matrix
constituents serve as anchoring substrates for cells in
tumours, thus directly affecting cell phenotype and dis-
semination [27]. In our study we have therefore chosen
to study the expression of integrin subunits which are
components of the ubiquitously expressed collagen
receptor (integrin a2b1), and the fibronectin receptor
(integrin a5b1). In pilot experiments, we show that the
three integrin subunits selected for analyses all partici-
pate importantly to the migratory function of CAFs
(Additional file 2: Figure S2). AIR provoked a donor-
independent elevation in surface expression of all three
integrins examined (a2, b1, a5) (Figure 6B). When
values from three different donors were averaged, integ-
rin a2 presented the most prominent response to AIR,
with a 5.8-fold increase relative to controls, whereas
integrins b1 and a5 were enhanced by factors of 1.8 and
2.7, respectively (Figure 6C). Expression levels of
integrin a2 in whole cell lysates from two randomly
selected donors (Figure 6D) demonstrated no difference
between control and irradiated groups, indicating that
changes were caused by redistribution of integrins rather
than up-regulated expression.
Discussion
This study was undertaken to shed light on the biologi-
cal responses of cells from the stroma of lung tumours
exposed to high radiation doses, proven to be successful
in the treatment of medically inoperable NSCLCs. We
show that ablative radiation doses exert therapeutically
beneficial inhibitory effects on the proliferative, migra-
tory and invasive capacity of CAFs, effects which are
associated with increased focal adhesions, cell surface
expression of integrins and modulation of MMP
secretion.
Our initial experiments showed that radiation had a
donor-independent inhibitory effect on the proliferative
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Figure 5 Secretion of matrix metalloproteases and endogenous inhibitors by CAFs. In panel (A), average determinations of the MMPs
levels found in culture supernatants 4 to 6 days post-irradiation from 5 donors is represented (donors #1, #5, #7, #11, #14 in Table 1). Only
MMPs that showed values above the detection limit of the assay are shown. Pale grey bars non-irradiated cultures; dark grey bars cells receiving
(1 × 18 Gy). Statistically significant differences between control and irradiated cultures were observed for MMP-3 (p < 0.05), and in four out of
five donors for MMP-1 (p = 0.06 all donors; p < 0.05 excluding donor-1). In panel (B), expression patterns of TIMP-1, -2, -3 from the same
supernatants used in (A) are shown.
Hellevik et al. Radiation Oncology 2012, 7:59
http://www.ro-journal.com/content/7/1/59
Page 9 of 13
α2 ab-free crtl
0 Gy
18 Gy
C
ou
nt
s
100
80
60
40
20
0
101 102 103 104
A
0 Gy
18 Gy
24 hrs
18 Gy
120 hrs
B
β1α2 α5
0
2
4
6
8
re
la
tiv
e 
le
ve
l
Integrin
18Gy
0 Gy
*
*
*
Donor 1 Donor 1
0 Gy 0 Gy
integrin α2 150 kDa
β-actin 43 kDa
18 Gy 18 Gy
β1
C
ou
nt
s
100
80
60
40
20
0
101 102 103 104
α5
Fluorescence
C
ou
nt
s
100
80
60
40
20
0
101 102 103 104
C
D
Figure 6 Dynamics of focal contacts and changes in the expression of cell surface integrins. Panels in (A) show AIR-induced changes of
focal contacts by vinculin immunostaining, panels in (B) show FACS analyses of three different integrin subtypes (a2, b1, a5) in non-
permeabilized CAFs from one representative donor (donor #1 in Table 1). In (C), mean and standard error of the fluorescent intensities of control
(pale grey) and irradiated (dark grey) CAFs from three randomly selected donors (donors #1, #5, and #14) is presented. Intensities at irradiated
conditions are relative-values of the non-irradiated and normalized control values, indicating X-fold enhancement of cell surface expression after
1 × 18 Gy. Statistical significance was set at p < 0.05 by applying Student’s paired t-test. In panel (D), the total cellular pool of integrin subunit
a2 (~150 kDa) was analysed by Western blots in whole cell lysates from two randomly selected donors.
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capacity of CAFs that was likely to be a consequence of
radiation-induced senescence in a high proportion of
cells. Ionizing radiation is well known to induce the
same phenotype as replicative senescence, and is often
referred to as stress-induced premature senescence
(SIPS) [28]. In fibroblasts [13] and mesenchymal stem
cells [29] a senescent phenotype typically develops over
several days after exposure to IR. Such radiation-
induced senescent fibroblasts have been postulated to
retain metabolic function and to display tumour promot-
ing effects through paracrine secretion of pro-inflamma-
tory signals [13]. Furthermore, persistent DNA damage
signalling has been linked to the establishment of a an
irreversible senescent phenotype [13,25,26], and is also
suggested as an indicator of lethal DNA damage [30].
On these premises we aimed to characterize the senes-
cent phenotype of human CAFs and measure the
kinetics of DNA damage foci several days post-irradia-
tion. In our study, CAFs showed a progressive increase
of b-galactosidase staining indicative of senescence, up
to 5 days after AIR. Concomitantly, nuclear foci contain-
ing DNA-damage response elements were robustly acti-
vated by AIR and lasted several days, thus supporting
the notion that a significant proportion of lung CAFs
enter permanent senescence after exposure to a tumour
ablative radiation dose.
Stromal fibroblasts are considered to be the master
regulators of matrix remodelling [5,6]. We explored the
influence of AIR on secretion by CAFs of key matrix
regulators including several MMPs and their endogen-
ous inhibitors; TIMPs. Our data show that only MMP-1
(collagenase), MMP-2 (gelatinase-A) and MMP-3 (stro-
melysin-1) are substantially secreted by lung CAFs. On
the contrary, MMP-7, MMP-8, MMP-9 and MMP-13
were undetectable within the limits of the assay. We
have observed by various means that MMP-9 is not sig-
nificantly expressed by neither irradiated nor control
lung CAFs, contributing to the notion that MMP-9 is
primarily expressed by tumour-infiltrating inflammatory
cells, rather than by CAFs [31].
A clear variation in expression among donors could be
observed for MMP-1 and MMP-3 at both early and late
time points after radiation. It remains to be explored if
inter-individual variation in the inherent expression of
these MMPs by CAFs has any impact on the overall
tumour response to radiation among patients. Radiation
was associated with changes in expression of MMP-1
and MMP-3, when examined 4 to 6 days after treat-
ment. Secreted MMP-1 protein-levels were significantly
reduced in 4 out of 5 cases, whereas MMP-3 levels were
enhanced in irradiated CAFs from all donors included
in the experiments. Patients with tumours expressing
MMP-1 at the primary site are reported to have a signif-
icantly worse prognosis than MMP-1 negative patients
[32]. The AIR-mediated reduction of MMP-1 expression
could, in part, explain the repressed invasiveness of
CAFs. To rule out this hypothesis we tested the invasive
capacity of CAFs in the presence of an MMP inhibitor,
GM1489 [33] (Additional file 1: figure S1). Our data
show that at a concentration of 1 nM of GM1489, an
amount that would inhibit over 90% of MMP-1 activity
and less than 1% of other MMPs, the rate of invasion is
reduced only 18%. These results indicate that MMP-1
only play a modest role for CAF invasion, at least as
observed in our in vitro assay, and its reduced expres-
sion may not account for the reduced invasion observed.
On the contrary, enhanced levels of MMP-3 might
represent a negative impact of AIR-based therapy, since
secreted MMP-3 has been reported to correlate with
tumorigenicity and invasiveness [34]. However, recent
studies indicate that MMP-3, as well as other MMPs,
may also have tumour-suppressive effects [35]. When
considering the catalytic activity and quantities of
MMPs, it must be taken into account that these pro-
teases are highly regulated at multiple levels, including
transcription, secretion, activation of the inactive pro-
enzymes, and finally, the counterbalancing effect
mediated by TIMPs [36]. We also found that TIMP-1,
TIMP-2 and to a lesser extent TIMP-3 are actively
secreted by lung CAFs. However, radiation exposure did
not mediate consistent stimulatory or inhibitory effects
on the TIMP levels.
CAF motility is a fundamental function supporting
tumour growth, invasiveness and angiogenesis. Cell
adhesion to ECM and locomotion is mediated by cell
surface receptors called integrins, whose ECM ligand
specificity is determined by combinations of a and b
integrin subunits [37,38]. Integrins expressed on stro-
mal fibroblasts contribute significantly in the regula-
tion of tumour development and metastasis by
affecting the migratory capacity of fibroblasts, by regu-
lating cell proliferation and survival, and by modifying
growth factor signalling [37]. In our study, we show a
dramatic redistribution of focal contacts upon AIR
that appears concomitantly with the acquirement of
the senescent phenotype. On the other hand, flow
cytometric analysis clearly demonstrated a radiation-
induced increase in surface expression of the integrin
subunits examined (a2, b1, a5). Expression levels in
whole cell lysates further revealed that the total pro-
tein pool of integrin a2 was unaffected after exposure
to 18 Gy, suggesting that the surface accumulation
was likely to be a consequence of reduced internaliza-
tion and/or enhanced recycling of integrins from the
intracellular pool [39]. Interestingly, a similar
enhancement (2-fold) of b1-integrin surface levels was
recently demonstrated in cancer cells with defective
endocytic machinery [40].
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Overall, our findings support the view that stabiliza-
tion of focal contacts (via integrins) increases attach-
ment and impairs migration of CAFs [41]. Radiation-
induced enhancement of cell adhesion has also been
demonstrated by Cordes and co-workers in various cell
types, and was reflected by increased cell-surface expres-
sion of b1-integrin [42]. In fact, augmentation of cell
surface expression of integrins, in particular b1-integrin,
has been postulated as a cellular mechanism to potenti-
ate anchorage-dependent pro-survival anti-apoptotic
pathways through binding to ECM components [43].
Furthermore, inhibition of b1-integrin reportedly med-
iate enhanced radioresponse, and has been suggested as
a therapeutic target [44].
Conclusions
Our data show that ablative radiation doses exert advanta-
geous inhibitory effects on the proliferative, migratory and
invasive capacity on CAFs, thus hindering some of their
pro-malignant properties. Reduction of MMP-1 expression
and enhanced accumulation of integrins at the cell surface
are two key phenotypic changes induced by AIR that
might explain the reduced motility of CAFs. The down-
stream consequences of these phenotypic changes on the
overall tumour response to AIR remain to be elucidated.
The interpretation of our results however needs some cau-
tiousness since the AIR-induced changes on CAFs’ pheno-
type and functions that we describe in this study could be
somehow transformed in the presence of lung cancer cells
or other stromal cells. Thus, the ultimate impact of irra-
diated fibroblasts on tumour development still needs to be
explored in more complex in vivo settings.
Additional material
Additional file 1: Figure S1 Role of MMPs on the invasive capacity by
CAFs. The activity of CAFs-derived MMPs was abrogated by the
exogenous administration of GM1489, a broad spectrum inhibitor of
matrix metalloproteinases with high affinity for MMP-1 (Ki = 0.2 nM). The
invasion assays were carried out at increasing concentration of the
inhibitor as indicated in Figure (A). At the lowest concentration of
inhibitor (1 nM) more than 90% of MMP-1 activity should be blocked,
however this amount if inhibitor exerted only 18% inhibition of invasion,
whereas the invasion rates were reduced to approximately 50% at the
highest concentration tested (10 μM) (B).
Additional file 2: Figure S2 Role of integrin b1, a2 and a5 on the
migratory function of CAFs. The participation of each integrin subunit
on the migratory capacity of CAFs was checked by measuring CAF
migration rates in the presence of specific integrin antibodies. Cells were
incubated with10 μg/ml of each antibody for 30 min at room
temperature before the assay and then tested for migration in the
continued presence of the antibodies. Wide-spectrum inhibition of
integrin binding was checked by administration of 100 μM RGD and
control peptides. All treatments, except control peptides and IgG, were
able to reduce extensively and permanently the migratory capacity of
CAFs.
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